Imagyn to buy Tyco’s ABBI breast biopsy assets

AuntMinnie.com staff writers

Sep 11, 2002

Medical device manufacturer Imagyn Medical Technologies of Irvine, CA, has signed a definitive agreement with Tyco Healthcare Group of Mansfield, MA, to purchase all assets related to Tyco's Advanced Breast Biopsy Instrumentation (ABBI) breast biopsy device. ABBI will join SiteSelect in Imagyn’s portfolio of large-core stereotactic breast biopsy devices. The transaction is expected to close on September 30.

By AuntMinnie.com staff writers
September 12, 2002
Related Reading

Breast biopsy technology evolves at a rapid pace, May 16, 2002

Copyright © 2002 AuntMinnie.com

Award-winning research: Screening mammograms showed variable lymph node morphology due to ectopic fat deposition in women with obesity. Image A (above) shows normal axillary lymph nodes measuring < 1.5 cm in 63-year-old woman with a body mass index (BM) = 43.2. Image B shows a possible fat-enlarged axillary node with large fatty hilum measuring 4.2 cm in a 52-year-old woman with a BMI = 45.8. Photo courtesy of American Roentgen Ray Society.

ARRS: Dartmouth poster wins for CVD risk prediction potential using mammograms

May 6, 2024

DBT + CEM boosts cancer detection in women with history of the disease

April 30, 2024

Mammogram Breast

USPSTF finalizes breast cancer screening recommendations

April 30, 2024

Screenshot (1152)

Large language models underperform in breast imaging

April 30, 2024

ARRS: Dartmouth poster wins for CVD risk prediction potential using mammograms

A poster on cardiovascular disease (CVD) risk prediction using fat-enlarged axillary nodes on mammograms won a prestigious award at ARRS 2024.

May 6, 2024

Award-winning research: Screening mammograms showed variable lymph node morphology due to ectopic fat deposition in women with obesity. Image A (above) shows normal axillary lymph nodes measuring < 1.5 cm in 63-year-old woman with a body mass index (BM) = 43.2. Image B shows a possible fat-enlarged axillary node with large fatty hilum measuring 4.2 cm in a 52-year-old woman with a BMI = 45.8. Photo courtesy of American Roentgen Ray Society.

DBT + CEM boosts cancer detection in women with history of the disease

By Kate Madden Yee

Adding contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) increases early breast cancer detection in women with a history of the disease.

April 30, 2024

USPSTF finalizes breast cancer screening recommendations

The USPSTF's final recommendations support breast cancer screening beginning at age 40, but don’t go as far as many screening advocates had hoped.

April 30, 2024

Mammogram Breast

Large language models underperform in breast imaging

By Amerigo Allegretto

Large language models such as ChatGPT and Google Gemini fall short in breast imaging.

April 30, 2024

Screenshot (1152)

U.S. federally qualified health centers show cancer screening gaps

By Kate Madden Yee

U.S. federally qualified health centers, intended to provide care to underserved populations across the country, show cancer screening gaps.

April 29, 2024

Breast Screening Mammo

RadNet teams up with basketball icon Sheryl Swoopes

By AuntMinnie.com staff writers

RadNet has tapped basketball legend and WNBA superstar Sheryl Swoopes as spokesperson for its nationwide breast cancer screening programs.

April 12, 2024

AI can be used to 'rule-out' breast cancer on mammography

By Erik L. Ridley

A deep-learning algorithm can rule out the presence of breast cancer on screening mammograms, improving specificity and yielding significant workflow and downstream savings.

April 10, 2024

Artificial Intelligence Ai Binary Code

AI helps select patients for supplemental breast cancer screening

By Erik L. Ridley

An AI-based method can outperform breast density measurements for flagging patients who would benefit from supplemental breast cancer screening.

April 9, 2024

Breast Cancer 3 D

Cryoablation effective in women with breast cancer

A minimally invasive procedure called cryoablation that uses ice to freeze and destroy tumors has proven effective for women with large breast cancer tumors.

March 27, 2024

FAPI-PET/CT outperforms FDG-PET/CT in women with invasive breast cancer

PET/CT imaging using gallium-68 FAPI radiotracer over F-18 FDG appears promising in women with invasive lobular carcinoma.

March 15, 2024

Maximum-intensity projection F-18 FDG-PET (left) and Ga-68 FAPI-PET (right) images of synchronous ILC. (A) A 42-year-old patient with multicentric primary lesions (encircled), regional (solid arrows), and distant inferior jugular lymph node (dashed arrows) seen on F-18 FDG-PET and subsequently confirmed on Ga-68 FAPI-PET, which also revealed additional malignant foci aligned with MRI. Some lesions exhibited high activity retention on Ga-68 FAPI-PET. (B) A 53-year-old patient showing no significant uptake on F-18 FDG-PET but synchronous bilateral lesions (arrows) on Ga-68 FAPI-PET, which also identified pathologic lymph nodes (encircled), resulting in upstaging. Image courtesy of the Journal of Nuclear Medicine.

Use CAD to assess breast tissue volume on MRI

By Kate Madden Yee

Using CAD software to assess enhancing breast tissue as a percentage of the entire breast volume on contrast MR imaging could improve breast cancer diagnosis.

March 14, 2024

Mri Breast Cancer

Imaging surveillance suggested for radial scars found on DBT

By Amerigo Allegretto

Imaging surveillance may be the way to go for tracking radial scars without atypia found on screening DBT.

March 14, 2024

Images taken from a 40-year-old woman with calcifications detected on baseline screening mammography show (A) lateral and (B) craniocaudal magnification views for grouped pleomorphic calcifications in right breast (circles). Stereotac-tic-guided core-needle biopsy yielded radial scar without atypia. Subsequent surgical resection yielded radial scar (i.e., not upstaged). Image courtesy of ARRS.

Page 1 of 569